Información del artículo
El Texto completo está disponible en PDF
Biblografía
[2.]
P. Gines, E. Quintero, V. Arroyo, J. Teres, M. Bruguera, A. Rimola, et al.
Compensated cirrhosis: natural history and prognostic factors.
Hepatology, 7 (1987), pp. 122-128
[3.]
G. D'Amico, A. Morabito, L. Pagliaro, E. Marubini.
Survival and prognostic indicators in compensated and decompensated cirrhosis.
Dig Dis Sci, 31 (1986), pp. 468-475
[4.]
B.A. Runyon.
Management of adult patients with ascites caused by cirrhosis.
Hepatology, 27 (1998), pp. 264-272
[5.]
B.B. Goldberg, G.A. Goodman, H.R. Clearfield.
Evaluation of ascites by ultrasound.
Radiology, 96 (1970), pp. 15-22
[6.]
M.G. Alexandrakis, J.A. Moschandrea, S.A. Koulocheri, E. Kouroumalis, G.D. Eliopoulos.
Discrimination between malignant and nonmalignant ascites using serum and ascitic fluid proteins in a multivariate analysis model.
Dig Dis Sci, 45 (2000), pp. 500-508
[7.]
V. Arroyo, P. Gines, A.L. Gerbes, F.J. Dudley, P. Gentilini, G. Laffi, et al.
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
Hepatology, 23 (1996), pp. 164-176
[8.]
R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, R. Williams.
Transection of the oesophagus for bleeding oesophageal varices.
Br J Surg, 60 (1973), pp. 646-649
[9.]
P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, C.L. Kosberg, et al.
A model to predict survival in patients with end-stage liver disease.
Hepatology, 33 (2001), pp. 464-470
[10.]
M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, J. Rank, P.C. Ter Borg.
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
Hepatology, 31 (2000), pp. 864-871
[11.]
V. Arroyo, J. Bosch, J. Gaya-Beltran, D. Kravetz, L. Estrada, F. Rivera, et al.
Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites.
Ann Intern Med, 94 (1981), pp. 198-201
[12.]
G. Fernández-Esparrach, A. Sánchez-Fueyo, P. Ginés, J. Uriz, L. Quinto, P.J. Ventura, et al.
A prognostic model for predicting survival in cirrhosis with ascites.
J Hepatol, 34 (2001), pp. 46-52
[13.]
J. Llach, P. Gines, V. Arroyo, A. Rimola, L. Tito, S. Badalamenti, et al.
Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.
Gastroenterology, 94 (1988), pp. 482-487
[14.]
K.P. Moore, F. Wong, P. Gines, M. Bernardi, A. Ochs, F. Salerno, et al.
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
Hepatology, 38 (2003), pp. 258-266
[15.]
A. Rimola, G. García-Tsao, M. Navasa, L.J. Piddock, R. Planas, B. Bernard, et al.
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.
J Hepatol, 32 (2000), pp. 142-153
[16.]
M. Navasa, F. Casafont, G. Clemente, C. Guarner, M. De la Mata, R. Planas, et al.
Consenso sobre peritonitis bacteriana espontánea en la cirrosis hepática: diagnóstico, tratamiento y profilaxis.
Gastroenterol Hepatol, 24 (2001), pp. 37-46
[17.]
S.S. Wu, O.S. Lin, Y.Y. Chen, K.L. Hwang, M.S. Soon, E.B. Keeffe.
Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation.
J Hepatol, 34 (2001), pp. 215-221
[18.]
E.A. Akriviadis, B.A. Runyon.
Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis.
Gastroenterology, 98 (1990), pp. 127-133
[19.]
B.A. Runyon, A.A. Montano, E.A. Akriviadis, M.R. Antillon, M.A. Irving, J.G. McHutchison.
The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.
Ann Intern Med, 117 (1992), pp. 215-220
[20.]
K.M. Chow, V.C. Chow, C.C. Szeto.
Indication for peritoneal biopsy in tuberculous peritonitis.
Am J Surg, 185 (2003), pp. 567-573
[21.]
R. Wiesner, E. Edwards, R. Freeman, A. Harper, R. Kim, P. Kamath, et al.
Model for end-stage liver disease (MELD) and allocation of donor livers.
Gastroenterology, 124 (2003), pp. 91-96
[22.]
M. Bernardi, C. Di Marco, F. Trevisani, L. Fornale, P. Andreone, C. Cursaro, et al.
Renal sodium retention during upright posture in preascitic cirrhosis.
Gastroenterology, 105 (1993), pp. 188-193
[23.]
H. Ring-Larsen, J.H. Henriksen, C. Wilken, J. Clausen, H. Pals, N.J. Christensen.
Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.
Br Med J, 292 (1986), pp. 1351-1353
[24.]
S.P. Wilkinson, T.P. Jowett, J.D. Slater, V. Arroyo, H. Moodie, R. Williams.
Renal sodium retention in cirrhosis: relation to aldosterone and nephron site.
Clin Sci (Lond), 56 (1979), pp. 169-177
[25.]
V. Arroyo, P. Gines, J. Rodes.
Treatment of ascites in patients with cirrhosis of the liver.
J Hepatol, 2 (1986), pp. 504-512
[26.]
R. Bataller, V. Arroyo, P. Gines.
Management of ascites in cirrhosis.
J Gastroenterol Hepatol, 12 (1997), pp. 723-733
[27.]
B.A. Runyon.
Care of patients with ascites.
N Engl J Med, 330 (1994), pp. 337-342
[28.]
B.A. Runyon.
Treatment of patients with cirrhosis and ascites.
Semin Liver Dis, 17 (1997), pp. 249-260
[29.]
F. Salerno, P. Angeli, M. Bernardi, G. Laffi, O. Riggio, M. Salvagnini.
Clinical practice guidelines for the management of cirrhotic patients with ascites. Committee on Ascites of the Italian Association for the Study of the Liver.
Ital J Gastroenterol Hepatol, 31 (1999), pp. 626-634
[30.]
R.M. Pérez-Ayuso, V. Arroyo, R. Planas, J. Gaya, F. Bory, A. Rimola, et al.
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
Gastroenterology, 84 (1983), pp. 961-968
[31.]
L. Descos, A. Gauthier, V.G. Levy, H. Michel, A. Quinton, B. Rueff, et al.
Comparison of six treatments of ascites in patients with liver cirrhosis. A clinical trial.
Hepatogastroenterol, 30 (1983), pp. 15-20
[32.]
M. Bernardi, G. Laffi, M. Salvagnini, G. Azzena, S. Bonato, F. Marra, et al.
Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content.
Liver, 13 (1993), pp. 156-162
[33.]
R.C. Eggert.
Spironolactone diuresis in patients with cirrhosis and ascites.
Br Med J, 4 (1970), pp. 401-403
[34.]
M. Bernardi, D. Servadei, F. Trevisani, A.G. Rusticali, G. Gasbarrini.
Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites.
Digestion, 31 (1985), pp. 189-193
[35.]
A. Gatta, P. Angeli, L. Caregaro, F. Menon, D. Sacerdoti, C. Merkel.
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
Hepatology, 14 (1991), pp. 231-236
[36.]
L. Shear, S. Ching, G.J. Gabuzda.
Compartmentalization of ascites and edema in patients with hepatic cirrhosis.
N Engl J Med, 282 (1970), pp. 1391-1396
[37.]
P. Ginés, V. Arroyo, E. Quintero, R. Planas, F. Bory, J. Cabrera, et al.
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.
Gastroenterology, 93 (1987), pp. 234-241
[38.]
E. Quintero, P. Ginés, V. Arroyo, A. Rimola, F. Bory, R. Planas, et al.
Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites.
Lancet, 1 (1985), pp. 611-612
[39.]
G. Fernández-Esparrach, M. Guevara, P. Sort, A. Pardo, W. Jiménez, P. Ginés, et al.
Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
J Hepatol, 26 (1997), pp. 614-620
[40.]
A. Ginés, G. Fernández-Esparrach, A. Monescillo, C. Vila, E. Domenech, R. Abecasis, et al.
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.
Gastroenterology, 111 (1996), pp. 1002-1010
[41.]
L. Tito, P. Ginés, V. Arroyo, R. Planas, J. Panes, A. Rimola, et al.
Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites.
Gastroenterology, 98 (1990), pp. 146-151
[42.]
M.C. Vila, S. Coll, R. Sola, M. Andreu, J. Gana, J. Márquez.
Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.
Am J Gastroenterol, 94 (1999), pp. 2219-2223
[43.]
V. Arroyo, A. Ginés, J. Salo.
A European survey on the treatment of ascites in cirrhosis.
J Hepatol, 21 (1994), pp. 667-672
[44.]
A.L. Gerbes, V. Gulberg, T. Waggershauser, J. Holl, M. Reiser.
Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites.
Hepatology, 28 (1998), pp. 683-688
[45.]
P. Ginés, J. Uriz, B. Calahorra, G. García-Tsao, P.S. Kamath, L.R. Del Árbol, et al.
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Gastroenterology, 123 (2002), pp. 1839-1847
[46.]
A.J. Sanyal, C. Genning, K.R. Reddy, F. Wong, K.V. Kowdley, K. Benner, et al.
The north american study for the treatment of refractory ascites.
Gastroenterology, 124 (2003), pp. 634-641
[47.]
D. Lebrec, N. Giuily, A. Hadengue, V. Vilgrain, R. Moreau, T. Poynard, et al.
Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.
J Hepatol, 25 (1996), pp. 135-144
[48.]
P. Ginés, T. Berl, M. Bernardi, D.G. Bichet, G. Hamon, W. Jiménez, et al.
Hyponatremia in cirrhosis: from pathogenesis to treatment.
Hepatology, 28 (1998), pp. 851-864
[49.]
V. Arroyo, J. Rodes, M.A. Gutiérrez-Lizarraga, L. Revert.
Prognostic value of spontaneous hyponatremia in cirrhosis with ascites.
Am J Dig Dis, 21 (1976), pp. 249-256
[50.]
M. Epstein.
Derangements of renal water handling in liver disease.
Gastroenterology, 89 (1985), pp. 1415-1425
[51.]
A.L. Gerbes, V. Gulberg, P. Ginés, G. Decaux, P. Gross, H. Gandjini, et al.
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.
Gastroenterology, 124 (2003), pp. 933-939
[52.]
F. Wong, A.T. Blei, L.M. Blendis, P.J. Thuluvath.
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
Hepatology, 37 (2003), pp. 182-191
[53.]
D. Guyader, A. Patat, E.J. Ellis-Grosse, G.P. Orczyk.
Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites.
Hepatology, 36 (2002), pp. 1197-1205
[54.]
M.H. Koppel, J.W. Coburn, M.M. Mims, H. Goldstein, J.D. Boyle, M.E. Rubini.
Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease.
N Engl J Med, 280 (1969), pp. 1367-1371
[55.]
S. Iwatsuki, M.M. Popovtzer, J.L. Corman, M. Ishikawa, C.W. Putnam, F.H. Katz, et al.
Recovery from «hepatorenal syndrome» after orthotopic liver transplantation.
N Engl J Med, 289 (1973), pp. 1155-1159
[56.]
R.W. Schrier, V. Arroyo, M. Bernardi, M. Epstein, J.H. Henriksen, J. Rodes.
Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
Hepatology, 8 (1988), pp. 1151-1157
[57.]
J.P. Mulkay, H. Louis, V. Donckier, N. Bourgeois, M. Adler, J. Deviere, et al.
Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.
Acta Gastroenterol Belg, 64 (2001), pp. 15-19
[58.]
I. Colle, F. Durand, F. Pessione, E. Rassiat, J. Bernuau, E. Barriere, et al.
Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with terlipressin: a retrospective analysis.
J Gastroenterol Hepatol, 17 (2002), pp. 882-888
[59.]
C. Halimi, P. Bonnard, B. Bernard, P. Mathurin, A. Mofredj, V. Di Martino, et al.
Effect of terlipressin (glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study.
Eur J Gastroenterol Hepatol, 14 (2002), pp. 153-158
[60.]
R. Moreau, F. Durand, T. Poynard, C. Duhamel, J.P. Cervoni, P. Ichai, et al.
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.
Gastroenterology, 122 (2002), pp. 923-930
[61.]
R. Ortega, P. Ginés, J. Uriz, A. Cárdenas, B. Calahorra, H.D. De Las, et al.
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.
Hepatology, 36 (2002), pp. 941-948
[62.]
M. Guevara, P. Ginés, J.C. Bandi, R. Gilabert, P. Sort, W. Jiménez, et al.
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
Hepatology, 28 (1998), pp. 416-422
[63.]
K.A. Brensing, J. Textor, J. Perz, P. Schiedermaier, P. Raab, H. Strunk, et al.
Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study.
Gut, 47 (2000), pp. 288-295
[64.]
S.R. Mitzner, S. Klammt, P. Peszynski, H. Hickstein, G. Korten, J. Stange, et al.
Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system.
Ther Apher, 5 (2001), pp. 417-422
[65.]
T. Restuccia, R. Ortega, M. Guevara, P. Ginés, C. Alessandria, O. Ozdogan, et al.
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A casecontrol study.
J Hepatol, 40 (2004), pp. 140-146
[66.]
P. Sort, M. Navasa, V. Arroyo, X. Aldeguer, R. Planas, L. Ruiz del Árbol, et al.
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
N Engl J Med, 341 (1999), pp. 403-409
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
